The lack of positive P/E or EV/EBITDA multiples renders traditional valuation frameworks largely inapplicable, forcing reliance on speculative P/S metrics that highlight the company's extreme premium relative to its current revenue base. This valuation appears to be driven by the scarcity of pure-play quantum hardware assets rather than operational success, warranting caution as the company's revenue contraction continues to inflate these multiples.

The persistent decay in return on invested capital suggests that the company's heavy capital expenditures are not yet translating into competitive advantages or scalable commercial output. Investors should monitor whether the recent shift toward gate fidelity improvements can eventually stabilize these returns, though current trends indicate that capital is being consumed faster than it can be effectively deployed.

The company's inability to turn its asset base into revenue suggests that the current scale of operations is far below what is required for self-sustainability. The high DSO figures, which reached 119 days in 2025Q4, further indicate that the company lacks leverage with its government and research partners, leading to extended collection cycles that exacerbate its liquidity constraints.

While the current ratio appears superficially healthy, it is heavily dependent on cash reserves that are being eroded by persistent operating losses. The lack of significant debt service obligations provides a temporary buffer, but the company's dependence on external equity markets for survival makes it highly susceptible to shifts in investor sentiment and capital market volatility.